Sergio Calvo, general manager of theranostics at GE HealthCare, joins MobiHealthNews to discuss how combining molecular ...

Gene therapy holds the promise of preventing and curing disease by manipulating gene expression within a patient's cells. However, to be effective, the new gene must make it into a cell's nucleus. The ...

ALIGARH, Feb. 5 -- Private Partnership (PPP) with Molecular Diagnostics and Therapy LLP to establish a state-of-the-art ...

City St. George’s researchers identified 9 genetic signatures and epigenetic changes driving lapatinib resistance in HER2-positive breast cancer. Cancer scientists from City St George’s, University of ...

More than 30 million people with HIV must take antiretroviral therapy (ART) medications daily to keep the virus under control ...

By targeting a cancer-driving pathway at multiple steps, a triple therapy stopped pancreatic tumors from developing ...

Gene therapy holds the promise of preventing and curing disease by manipulating gene expression within a patient's cells. However, to be effective, the new gene must make it into a cell's nucleus. The ...

Ongoing monitoring remains a cornerstone of survivorship care for patients with cancer, helping detect recurrence early and ...

An experimental pill called enlicitide slashed levels of low-density lipoprotein (LDL) cholesterol, commonly known as "bad" ...

Baystreet.ca News Commentary – The global oncology therapeutics market reached $164.2 billion in 2025 and is projected to hit $285.4 billion by 2030[1]; it signaled a massive ...

Scientists discover a molecule that shuts down a brain cancer (glioblastoma)-driving gene, offering hope beyond surgery, ...

The biopharmaceutical sector is transitioning from reactive off-line quality control to a proactive quality by design (QbD) framework. Process analytical technology (PAT) enables this shift through ...